Goldman Sachs Group Inc Gritstone Bio, Inc. Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.62 - $2.35 $423,517 - $1.61 Million	683,093 Added 143.27%	1,159,891 $719,000
Q1 2024 May 15, 2024	BUY	$1.96 - $2.9 $665,702 - $984,967	339,644 Added 247.64%	476,798 $1.23 Million
Q4 2023 Feb 13, 2024	SELL	$1.28 - $2.85 $62,152 - $138,387	-48,557 Reduced 26.15%	137,154 $279,000
Q3 2023 May 14, 2024	BUY	$1.19 - $2.26 $57,782 - $109,738	48,557 Added 35.4%	185,711 $319,000
Q3 2023 Nov 14, 2023	BUY	$1.19 - $2.26 $66,030 - $125,402	55,488 Added 42.61%	185,711 $319,000
Q2 2023 May 14, 2024	SELL	$1.66 - $3.03 $241,599 - $440,992	-145,542 Reduced 52.78%	130,223 $253,000
Q2 2023 Aug 14, 2023	SELL	$1.66 - $3.03 $241,599 - $440,992	-145,542 Reduced 52.78%	130,223 $253,000
Q1 2023 May 14, 2024	BUY	$2.13 - $3.74 $321,487 - $564,489	150,933 Added 120.91%	275,765 $766,000
Q1 2023 May 11, 2023	BUY	$2.13 - $3.74 $321,487 - $564,489	150,933 Added 120.91%	275,765 $766,000
Q4 2022 May 14, 2024	BUY	$2.17 - $3.92 $1,618 - $2,924	746 Added 0.6%	124,832 $430,000
Q4 2022 Feb 13, 2023	BUY	$2.17 - $3.92 $1,618 - $2,924	746 Added 0.6%	124,832 $430,000
Q3 2022 May 14, 2024	SELL	$2.46 - $4.75 $78,545 - $151,662	-31,929 Reduced 20.47%	124,086 $319,000
Q3 2022 Nov 10, 2022	SELL	$2.46 - $4.75 $78,545 - $151,662	-31,929 Reduced 20.47%	124,086 $0
Q2 2022 May 14, 2024	BUY	$1.77 - $4.34 $33,383 - $81,856	18,861 Added 13.75%	156,015 $378,000
Q2 2022 Aug 15, 2022	SELL	$1.77 - $4.34 $236,971 - $581,047	-133,882 Reduced 46.18%	156,015 $378,000
Q1 2022 May 16, 2022	SELL	$4.03 - $12.19 $612,011 - $1.85 Million	-151,864 Reduced 34.38%	289,897 $1.19 Million
Q4 2021 Feb 14, 2022	BUY	$8.76 - $13.71 $3.32 Million - $5.2 Million	378,936 Added 603.16%	441,761 $5.68 Million
Q3 2021 Nov 10, 2021	BUY	$6.41 - $13.54 $402,708 - $850,650	62,825 New	62,825 $679,000

Others Institutions Holding GRTS

# of Institutions

Shares Held

35.4M

Call Options Held

395K

Put Options Held

132K

View Full List

About Gritstone bio, Inc.

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

More about GRTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account